 |
 Video: What is a Stock Split?
|
|
|
| Wave Life Sciences is a clinical-stage genetic medicines company. Co. has a pipeline of programs. Co.'s primary programs are designed to treat genetic diseases, which include: WVE-N531 (splicing), its exon 53 molecule for the treatment of Duchenne muscular dystrophy; WVE-006 (editing), its SERPINA1 molecule for the treatment of alpha-1 antitrypsin deficiency; WVE-003 (silencing), its mutant huntingtin single nucleotide polymorphism three molecule for the treatment of Huntington's disease; and WVE-004 (silencing), its C9orf72 molecule for the treatment of C9orf72-associated amyotrophic lateral sclerosis and frontotemporal dementia. According to our Wave Life Sciences stock split history records, Wave Life Sciences has had 0 splits. | |
|
Wave Life Sciences (WVE) has 0 splits in our Wave Life Sciences stock split history database.
Looking at the Wave Life Sciences stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Wave Life Sciences shares, starting with a $10,000 purchase of WVE, presented on a split-history-adjusted basis factoring in the complete Wave Life Sciences stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
11/13/2015 |
|
| End date: |
04/19/2024 |
|
| Start price/share: |
$15.90 |
|
| End price/share: |
$4.87 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-69.37% |
|
| Average Annual Total Return: |
-13.09% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$3,062.07 |
|
| Years: |
8.44 |
|
|
|
|
|
